D-0049-2024 Class I Terminated

Recalled by KVK-Tech, Inc. — Newtown, PA

FDA drug recall D-0049-2024 was initiated by KVK-Tech, Inc. on Sep 20, 2023 and is designated Class I. Reason for recall: Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles. The recall status is terminated (terminated Jul 29, 2025). Affected quantity: 1488 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 25, 2023
Initiation Date
Sep 20, 2023
Termination Date
Jul 29, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1488 bottles

Product description

Betaxolol Tablets, USP 10 mg, Rx Only, 100 count bottles, Mfd by: KVK Tech Inc., Newtown, PA 18940, Made in USA, NDC# 10702-013-01.

Reason for recall

Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.

Distribution pattern

Nationwide in the USA and PR

Code information

Lot # 17853A, Exp. 06/30/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0049-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0049-2024. Report a data issue: hello@regdatalab.com.